No Data
Biotricity Files 50M Mixed Securities Shelf
Express News | Biotricity Inc Files for Mixed Shelf of up to $50 Mln - SEC Filing
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships With Two Leading Home-Based Diagnostic Companies
REDWOOD CITY, CA / ACCESSWIRE / April 30, 2024 / Biotricity Inc. (NASDAQ:BTCY), a groundbreaking Technology-as-a-Service (TaaS) company committed to delivering cutting-edge medical and consumer diagno
Express News | Biotricity Announces High Demand For Its LBiotres Pro, a 3-Channel Patch-like ECG, Biotres Pro Is Expected To Raise The Average Subscription Price By Over 32%, Translating To Revenue Increase Of Up To 10% From Sales To Existing Customers Throughout 2025
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest From Existing and New Customers
Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a pioneering Technology-as-a-Service (TaaS) company dedicated to delivering top-of-the-line medical diagnostic and consumer healthcare solutions, announces high demand for its latest breakthrough device, Biotres Pro.
Top Premarket Decliners
Air Industries Group (AIRI) shares slumped nearly 60% Friday premarket, adding to Thursday's slide. Sunshine Biopharma (SBFM) shares were down nearly 18%, extending losses from the previous session. E